Wednesday 12th October 2022 |
Text too small? |
Rua Bioscience (NZX: RUA ) advises that all resolutions put to its hybrid Annual Shareholders’ Meeting (held online and in Gisborne today) were passed by Shareholders.
Those resolutions being:
- That the Board be authorised to fix the auditor’s remuneration.
- That Trevor Burt be re-elected as a director of Rua.
- That Brett Gamble be re-elected as a director of Rua.
- That Teresa Ciprian be re-elected as a director of Rua.
The results of the voting poll are in the attached document.
Ends
For more information, please visit www.ruabio.com or contact:
Media
Kerry Donovan
Communications Manager
+64 (21) 128 7689
kerry.donovan@ruabio.com
Investors
Hamish White
Chief Financial Officer
+64 (21) 050 5795
Hamish.white@ruabio.com
Rua Bioscience Results of the 2022 Annual Shareholders' Meeting
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b